Cancer Genomics & Proteomics

Visit the official website of the International Institute of Anticancer Research

Current Issue

November-December 2024 (Vol. 21 Issue 6) Table of Contents

Issue highlights

GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma
Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines

Two Special Issues are coming in 2025:

Cancer Invasion and Metastasis Mechanisms - 2025 (Submission deadline: May 30, 2025; Publication date: September 2025). Click here for more information.
Transcriptomics: Identification of Fusion Transcripts; Non-coding RNAs; Discovery of New Transcripts - 2025 (Submission deadline: September 30, 2025; Publication date: January 2026). Click here for more information.

Latest Articles

Open Access
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics November 2024, 21 (6) 585-590; DOI: https://doi.org/10.21873/cgp.20475
Open Access
Comparative Proteomics of ccRCC Cell Lines to Identify Kidney Cancer Progression Factors
JUHEE PARK, HYUNCHAE SIM, EUN HYE LEE, BUM SOO KIM, JAE-WOOK CHUNG, YUN-SOK HA, TAE GYUN KWON, SANGKYU LEE and JUN NYUNG LEE

Cancer Genomics & Proteomics November 2024, 21 (6) 645-652; DOI: https://doi.org/10.21873/cgp.20480
Open Access
Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines
YEONSOO CHAE, JUNGWOOK ROH, MIJUNG IM, WONYI JANG, BOSEONG KIM, JIHOON KANG, BUHYUN YOUN and WANYEON KIM

Cancer Genomics & Proteomics November 2024, 21 (6) 608-621; DOI: https://doi.org/10.21873/cgp.20477
Open Access
GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
TOMOYUKI TATENUMA, TAKUO MATSUKAWA, TAKURO GOTO, GUIYANG JIANG, ADHYA SHARMA, MOHAMMAD AMIN ELAHI NAJAFI, YUKI TERAMOTO and HIROSHI MIYAMOTO

Cancer Genomics & Proteomics November 2024, 21 (6) 557-565; DOI: https://doi.org/10.21873/cgp.20472
Open Access
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines
ARMIN VON FOURNIER, CHRISTIAN WILHELM, CLARA TIRTEY, MANUEL STÖTH, TOTTA EHRET KASEMO, STEPHAN HACKENBERG and AGMAL SCHERZAD

Cancer Genomics & Proteomics November 2024, 21 (6) 591-607; DOI: https://doi.org/10.21873/cgp.20476
Open Access
Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
SACHIKO INUBUSHI, TOMONARI KUNIHISA, MARINA KUNIYASU, SHOTARO INOUE, MAYUKO YAMAMOTO, YUJI YAMASHITA, MAYUKO MIKI, SACHIKO MIZUMOTO, MOTOI BABA, ROBERT M. HOFFMAN and HIROKAZU TANINO

Cancer Genomics & Proteomics November 2024, 21 (6) 580-584; DOI: https://doi.org/10.21873/cgp.20474

Visit the official website of Cancer Genomics & Proteomics.

Main menu

User menu

Search

Visit the official website of the International Institute of Anticancer Research

Current Issue

Issue highlights

Featured Articles

Latest Articles

Access CGP at your Mobile Device